Mark Snyder is a seasoned communications executive currently serving as the Vice President of Public Affairs at Gilead Sciences. With a robust leadership background in the Biotech/Pharma industry, Mark has been instrumental in shaping brand-building strategies across various therapeutic areas, including virology, oncology, and inflammation. Having held significant roles at organizations like ZymoGenetics, Amgen, and Immunex, Mark has overseen communications strategies for over ten product launches and has navigated complex business challenges while advocating for public health. Mark’s approach combines a consumer-centric focus with strategic collaboration, fostering cohesive teams to drive impactful communications and success in the marketplace.
This person is not in any teams
This person is not in any offices